Back
InflaRx NV Vs. ATAI Life Sciences NV Industry Stock Comparison
Sell
33
IFRX
InflaRx NV
Last Price:
1.49
Seasonality Move:
-2.81%
Sell
36
ATAI
ATAI Life Sciences NV
Last Price:
1.28
Seasonality Move:
-25.34%
Sell
33
InflaRx NV (IFRX)
is a Sell
Is InflaRx NV a Buy, Sell or Hold?
- The current InflaRx NV [IFRX] share price is $1.45. The Score for IFRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- IFRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
ATAI Life Sciences NV (ATAI)
is a Sell
Is ATAI Life Sciences NV a Buy, Sell or Hold?
- The current ATAI Life Sciences NV [ATAI] share price is $1.24. The Score for ATAI is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- ATAI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IFRX Stock Price Chart
What is InflaRx NV's stock price today?
-
The InflaRx NV share price today is $1.45
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IFRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ATAI Stock Price Chart
What is ATAI Life Sciences NV's stock price today?
-
The ATAI Life Sciences NV share price today is $1.24
The current trend is relatively stagnant and ATAI is experiencing selling pressure, which indicates risk of future bearish movement.
IFRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 44.54 | Sell |
Chaikin Money Flow: | 18326 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.41 - 1.59) | Sell |
Bollinger Bands (100): | (1.38 - 1.62) | Sell |
ATAI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 45.03 | Sell |
Chaikin Money Flow: | -275116 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.22 - 1.3) | Sell |
Bollinger Bands (100): | (1.22 - 1.74) | Sell |
IFRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.46 | Sell |
20-day SMA: | 1.53 | Sell |
50-day SMA: | 1.5 | Sell |
200-day SMA: | 1.54 | Sell |
8-day EMA: | 1.47 | Sell |
20-day EMA: | 1.49 | Sell |
50-day EMA: | 1.5 | Sell |
200-day EMA: | 1.71 | Sell |
ATAI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.26 | Sell |
20-day SMA: | 1.26 | Sell |
50-day SMA: | 1.36 | Sell |
200-day SMA: | 1.63 | Sell |
8-day EMA: | 1.26 | Sell |
20-day EMA: | 1.27 | Sell |
50-day EMA: | 1.34 | Sell |
200-day EMA: | 1.58 | Sell |
InflaRx NV Earnings Growth & IFRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.17 per share.
ATAI Life Sciences NV Earnings Growth & ATAI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.45 per share, and an increase next year of $0.05 per share.
InflaRx NV Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ATAI Life Sciences NV Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |